Edwards Lifesciences Corp (EW)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	1,402,400	1,521,900	1,503,100	823,400	1,046,900
Total assets	US$ in thousands	9,363,200	8,292,500	8,502,600	7,237,100	6,488,100
ROA		14.98%	18.35%	17.68%	11.38%	16.14%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $1,402,400K ÷ $9,363,200K
= 14.98%

Over the past five years, Edwards Lifesciences Corp has demonstrated varying levels of return on assets (ROA) as follows:

- In 2023, the ROA was 14.98%, which represents a decrease compared to the previous year.
- In 2022, the ROA reached its peak at 18.35%, indicating a strong performance in utilizing its assets to generate profits.
- In 2021, the ROA was 17.68%, showing a slightly lower but still robust performance compared to the peak year.
- In 2020, the ROA was 11.38%, representing a noticeable decrease from the preceding years, suggesting potential challenges in asset utilization or profitability.
- In 2019, the ROA stood at 16.14%, which indicates a rebound from the lower performance in 2020.

Overall, the trend in ROA for Edwards Lifesciences Corp has shown fluctuations, with years of strong performance followed by periods of lower returns. It is important for the company to analyze the factors influencing these variations to ensure sustainable and improved asset utilization efficiency in the future.